Obesity Today—April 14, 2026
This week’s Obesity update highlights regulatory and commercial momentum,…
Obesity Today—April 7, 2026
This week’s Obesity update highlights regulatory progress, advancing late-stage…
AI in Healthcare and Digital Health Today—April 6, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1 asset
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1……
Obesity Today—March 31, 2026
This week’s Obesity update highlights regulatory progress, advancing late-stage…
Obesity Today—March 24, 2026
This week’s Obesity update highlights regulatory progress, advancing clinical…
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly…
Obesity Today—March 17, 2026
This week’s Obesity update highlights regulatory approvals, emerging generic…
Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide collaboration
Lucid Diligence Brief: Samsung Bioepis and G2GBIO long-acting semaglutide…
Obesity Today—March 10, 2026
This week’s Obesity update highlights regulatory approvals, emerging generic…
Obesity Video Recap—March 3, 2026
This biweekly Obesity video recap highlights late-stage combination data,…
AI in Healthcare and Digital Health Today—March 2, 2026
This week’s AI in Healthcare and Digital Health update highlights…